Valuation dashboard for OSR Holdings, Inc. (OSRH) with P/E N/A, P/B 0.01, EV/EBITDA -0.38 and dividend yield 0.00%. DCF, Graham Number and Earnings Power Value models plus sector comparison against other Healthcare companies.
OSR Holdings, Inc. operates as a Special Purpose Acquisition Company (SPAC) – essentially a blank check entity. Its primary objective is to execute a substantial business combination, which may take the form of a merger, a capital stock exchange, an asset acquisition, a stock purchase, a reorganization, or other comparable strategic transaction with one or more established businesses.
Analysis Summary
Trailing-twelve-month margins: gross margin -98.8%, operating margin -9.3%, net margin -8.4%.
At the current price of $0.12, OSRH has negative trailing earnings (P/E not meaningful) and an ROE of -16.47%. Market capitalisation stands at $4M.
Balance sheet quality for OSRH: current ratio of 0.2. A debt-to-equity below 1.0 typically signals conservative capital structure, while a current ratio above 1.5 indicates comfortable short-term liquidity.
Valuation Ratios
| Price / Book | 0.01 |
| EV / EBITDA | -0.38 |
| Dividend Yield | 0.00% |
Valuation Models
| DCF Fair Value | $6.24 |
| vs Current Price | +5253.0% |
Peer Comparison
| Symbol | Company | Market Cap | P/E | P/B | ROE |
|---|---|---|---|---|---|
| OSRH | OSR Holdings, Inc. | $4M | 0.01 | -16.5% | |
| 0QZU.L | Vertex Pharmaceuticals Incorporated | $131.8B | |||
| VRTX | Vertex Pharmaceuticals Incorporated | $130.3B | 29.68 | 6.45 | 23.3% |
| 0R2M.L | Regeneron Pharmaceuticals, Inc. | $84.0B | |||
| REGN | Regeneron Pharmaceuticals, Inc. | $79.8B | 18.79 | 2.57 | 13.8% |
| ARGX | argenx SE | $61.2B | 36.30 | 7.40 | 21.7% |
| MRNA | Moderna, Inc. | $57.8B | 1.34 | -39.2% | |
| RVMD | Revolution Medicines, Inc. | $41.7B | 15.96 | -96.4% |
Price
| Price | $0.12 |
| Market Cap | $4M |
| Exchange | NASDAQ |
| Country | US |
Profitability
| Return on Equity | -16.47% |
| Return on Invested Capital | -10.61% |
| Return on Assets | -9.08% |
| Gross Margin | -98.82% |
| Operating Margin | -933.75% |
| Net Margin | -836.91% |
Related companies: ATIF · BNIX · BRLI · CETU · EONR · JVSA · RFAC
Explore sector: Healthcare · Biotechnology
More sections of OSRH: Overview · Financials · Statistics · Estimates · Technical · Ownership · News · Events
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks